Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo

Human Gene Therapy

Volumn 7, Issue 15, 1996, Pages 1827-1836

  Veelken, Hendrik ^a   Re, Daniel ^a   Kulmburg, Peter ^a   Rosenthal, Felicia M ^a   Mackensen, Andreas ^a   Mertelsmann, Roland ^a   Lindemann, Albrecht ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CELL DESTRUCTION; CELL SELECTION; CISTRON; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; DRUG SENSITIVITY; ENCEPHALOMYOCARDITIS VIRUS; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOCYTOSIS; MARKER GENE; MOUSE; NONHUMAN; PLASMID; PROMOTER REGION; RIBOSOME; TRANSCRIPTION REGULATION; TRANSGENE; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; HERPES; SIMPLEXVIRUS;

EID: 0029856696     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.15-1827     Document Type: Article

References (37)

1. ARAN, J.M., GOTTESMAN, M.M., and PASTAN, I. (1994). Drug-selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc. Natl. Acad. Sci. USA 91, 3176-3180.
2. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
3. BUHLES, W.C., MASTRE, B.J., TINKER, A.J., STRAND, V., and KORETZ, S.H. (1988). Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev. Infect. Dis. 10(Suppl. 3.), S495-506.
4. CHALLITA, P.-M, and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91, 2567-2571.
5. CHALLITA, P.-M., SKELTON, D., EL-KHOUEIRY, A., YU, X.-J., WEINBERG, K., and KOHN, D.B. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA hypermethylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
6. COLOMBO, M.P., FERRARI, G., STOPPACCIARO, A., PARENZA, M., RODOLFO, M., MAVILIO, F., and PARMIANI, G. (1991). Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 173, 889-897.
7. COTTEN, M., BAKER, A., SALTIK, M., WAGNER, E., and BUSCHLE, M. (1994). Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary cells in the presence of adenovirus. Gene Ther. 1, 239-246.
8. GIORDANO, T.J., and ALLISTER, W.T. (1990). Optimization of the hygromycin B resistance-conferring gene as a dominant selectable marker in mammalian cells. Gene 88, 285-288.
9. JANG, S.K., DAVIES, M.V., KAUFMAN, R.J., and WIMMER, E. (1989). Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63, 1651-1660.
10. LEVINE, F., YEE, J.K., and FRIEDMANN, T. (1991). Efficient gene expression in mammalian cells from a dicistronic transcription unit in an improved retroviral vector. Gene 108, 167-174.
11. LUPTON, S.D., BRUNTON, L.L., KALBERG, V.A., and OVERELL, R.W. (1991). Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11, 3374-3378.
12. MOOLTON, F.L., and WELLS, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
13. MOULLIER, P., BOHL, D., CARDOSO, J., HEARD, J.M., and DANOS, O. (1995). Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nature Med. 1, 353-357.
14. MULLEN, C.A. (1994). Metabolic suicide genes in gene therapy. Pharmacol. Ther. 63, 199-207.
15. NAFFAKH, N., HENRI, A., VILLEVAL, J.L., ROUYER-FESSARD, P., MOULLIER, P., BLUMENFELD, N., DANOS, O., VAINCHENKER, W., HEARD, J.M., and BEUZARD, Y. (1995). Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc. Natl. Acad. Sci. USA 92, 3194-3198.
16. 60Co gamma rays. Int. J. Cancer 35, 275-280.
17. NEHLS, M.C., KRAUSE, S., and BOEHM, T. (1994a). Neomycin- and hyagromycin-resistance expression cassettes containing an artificial triple helix-site and a synthetic lac operator facilitate restriction enconuclease cleavage at pre-defined sites and recovery of specific fragments from mammalian genomes. Mamm. Genome 5, 183-186.
18. NEHLS, M., MESSERLE, M., SIRULNIK, A., SMITH, A.J.H., and BOEHM, T. (1994b). Two large insert vectors, λPS and λKO, facilitate rapid mapping and targeted disruption of mammalian genes. BioTechniques 17, 770-775.
19. PALMER, T.D., ROSMAN, G.J., OSBORNE, W., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate foreign genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
20. PELLETIER, J., and SONENBERG, N. (1988). Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320-325.
21. RAMESH, N., LAU, S., PALMER, T.D., STORB, R., and OSBORNE, W.R.A. (1993). High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation. Hum. Gene Ter. 4, 3-7.
22. ROEHM, N.W., RODGERS, G.H., HATFIELD, S.M., and GLASEBROOK, A.L. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Meth. 142, 257-265.
23. ROSENTHAL, F.M., FRÜH, R.. HENSCHLER, R., VEELKEN, H., KULMBURG, P., MACKENSEN, A., GANSBACHER, B., MERTELSMANN, R., and LINDEMANN, A. (1994a). Cytokine therapy with gene-transfected cells-single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice. Blood 84, 2960-2965.
24. ROSENTHAL, F.M., CRONIN, K., BANNERJI, R., GOLDE, D.W., and GANSBACHER, B. (1994b). Augmentation of antitumor immunity by tumor cells carrying the interleukin-2 and interferon-gamma cDNAs. Blood 83, 1289-1298.
25. ROSENTHAL, F.M., KULMBURG, P., FRÜH, R., PFEIFER, C., KÖHLER, G., VEELKEN, H., MACKENSEN, A., LINDEMANN, A., and MERTELSMANN, R. (1996). Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected tumor cells and fibroblasts. Hum. Gene Ther. (in press).
26. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (eds.). (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
27. SCHARFMANN, R., AXELROD, J.H., and VERMA, I.M. (1991). Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-4630.
28. SCHWARTZ, F., MAEDA, N., SMITHIES, O., HICKEY, R., EDELMANN, W., SKOULTCHI, A., and KUCHERLAPATI, R. (1991). A dominant positive and negative selectable gene for use in mammalian cells. Proc. Natl. Acad. Sci. USA 88, 10416-10420.
29. SOUTHERN, P.J., and BERG, P. (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
30. SRIVASTAVA, P.K., DELEO, A.B., and OLD, L.J. (1986). Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83, 3407-3411.
31. TATE, P.H., and BIRD, A.P. (1993). Effects of DNA methylation on DNA binding proteins and gene expression. Curr. Opin. Genet. Dev. 3, 226-231.
32. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH, H.J., MCKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., ROBBINS, P.D., and LOTZE, M.T. (1995). Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic viral vector. J. Immunol. 154, 6466-6474.
33. TONIOLO, D., FILIPPI, M., DONO, R., LETTIERI, T., and MARTINI, G. (1991). The CpG island in the 5′ region of the G6PD gene of man and mouse. Gene 102, 179-203.
34. VEELKEN, H., JESUITER, H., MACKENSEN, A., KULMBURG, P., SCHULTZE, J., ROSENTHAL, F.M., MERTELSMANN, R., and LINDEMANN, A. (1994). Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum. Gene Ther. 5, 1203-1209.
35. VEELKEN, H., KULMBURG, P., KUNZMANN, R., SCHULTZE, J., ROSENTHAL, F.M., MACKENSEN, A., LAHN, M., MERTELSMANN, R., and LINDEMANN, A. Stable secretion of a recombinant cytokine by clonal populations of primary human skin fibroblasts after non-viral transfection. (Submitted for publication).
36. L promoter and a c1857 temperature-sensitive repressor. J. Biol. Chem. 19, 11571-11575.
37. ZIMMERMAN, A., NELSEN-SALZ, B., KRUPPENBACHER, J.P., and EGGERS, H.J. (1994). The complete nucleotide sequence and construction of an infectious cDNA clone of a highly virulent encephalomyocarditis virus. Virology 203, 366-372.